Selected research
Industry Research
Chloroquine Drug for COVID-19 Industry Research Report 2026
Market perspective
The global Chloroquine Drug for COVID-19 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Chloroquine Drug for COVID-19 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Chloroquine Drug for COVID-19 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Chloroquine Drug for COVID-19 include Zhongsheng Pharma, Sichuan Sunny Hope, Shanghai Pharma, Jinghua Pharmaceutical Group, North China Pharmaceutical Group, Guangzhou Baiyunshan Guanghua Pharmaceutical, Bayer, Sun Pharma and Rising Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Chloroquine Drug for COVID-19 market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chloroquine Drug for COVID-19 Market by Company
Zhongsheng Pharma
Sichuan Sunny Hope
Shanghai Pharma
Jinghua Pharmaceutical Group
North China Pharmaceutical Group
Guangzhou Baiyunshan Guanghua Pharmaceutical
Bayer
Sun Pharma
Rising Pharmaceutical
KPC Group
CSPC Group
Chloroquine Drug for COVID-19 Segment by Type
Tablet
Injection
Chloroquine Drug for COVID-19 Segment by Application
Mild Symptom Patient
Critically Ill Patient
Chloroquine Drug for COVID-19 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Drug for COVID-19 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Drug for COVID-19 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Drug for COVID-19.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chloroquine Drug for COVID-19 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chloroquine Drug for COVID-19 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chloroquine Drug for COVID-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Injection
Applications
- Mild Symptom Patient
- Critically Ill Patient
Companies covered
- Zhongsheng Pharma
- Sichuan Sunny Hope
- Shanghai Pharma
- Jinghua Pharmaceutical Group
- North China Pharmaceutical Group
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- Bayer
- Sun Pharma
- Rising Pharmaceutical
- KPC Group
- CSPC Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Chloroquine Drug for COVID-19 Market Size (2021-2032)
- 2.2.2 Global Chloroquine Drug for COVID-19 Sales (2021-2032)
- 2.2.3 Global Chloroquine Drug for COVID-19 Market Average Price (2021-2032)
- 2.3 Chloroquine Drug for COVID-19 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Injection
- 2.4 Chloroquine Drug for COVID-19 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Mild Symptom Patient
- 2.4.3 Critically Ill Patient
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Chloroquine Drug for COVID-19 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Chloroquine Drug for COVID-19 Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Chloroquine Drug for COVID-19 Revenue of Manufacturers (2021-2026)
- 3.4 Global Chloroquine Drug for COVID-19 Average Price by Manufacturers (2021-2026)
- 3.5 Global Chloroquine Drug for COVID-19 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Chloroquine Drug for COVID-19, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Chloroquine Drug for COVID-19, Product Type & Application
- 3.8 Global Manufacturers of Chloroquine Drug for COVID-19, Established Date
- 3.9 Global Chloroquine Drug for COVID-19 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhongsheng Pharma
- 4.1.1 Zhongsheng Pharma Company Information
- 4.1.2 Zhongsheng Pharma Business Overview
- 4.1.3 Zhongsheng Pharma Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhongsheng Pharma Chloroquine Drug for COVID-19 Product Portfolio
- 4.1.5 Zhongsheng Pharma Recent Developments
- 4.2 Sichuan Sunny Hope
- 4.2.1 Sichuan Sunny Hope Company Information
- 4.2.2 Sichuan Sunny Hope Business Overview
- 4.2.3 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Product Portfolio
- 4.2.5 Sichuan Sunny Hope Recent Developments
- 4.3 Shanghai Pharma
- 4.3.1 Shanghai Pharma Company Information
- 4.3.2 Shanghai Pharma Business Overview
- 4.3.3 Shanghai Pharma Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Pharma Chloroquine Drug for COVID-19 Product Portfolio
- 4.3.5 Shanghai Pharma Recent Developments
- 4.4 Jinghua Pharmaceutical Group
- 4.4.1 Jinghua Pharmaceutical Group Company Information
- 4.4.2 Jinghua Pharmaceutical Group Business Overview
- 4.4.3 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
- 4.4.5 Jinghua Pharmaceutical Group Recent Developments
- 4.5 North China Pharmaceutical Group
- 4.5.1 North China Pharmaceutical Group Company Information
- 4.5.2 North China Pharmaceutical Group Business Overview
- 4.5.3 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
- 4.5.5 North China Pharmaceutical Group Recent Developments
- 4.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
- 4.6.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
- 4.6.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
- 4.6.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
- 4.6.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Chloroquine Drug for COVID-19 Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Sun Pharma
- 4.8.1 Sun Pharma Company Information
- 4.8.2 Sun Pharma Business Overview
- 4.8.3 Sun Pharma Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharma Chloroquine Drug for COVID-19 Product Portfolio
- 4.8.5 Sun Pharma Recent Developments
- 4.9 Rising Pharmaceutical
- 4.9.1 Rising Pharmaceutical Company Information
- 4.9.2 Rising Pharmaceutical Business Overview
- 4.9.3 Rising Pharmaceutical Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Rising Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
- 4.9.5 Rising Pharmaceutical Recent Developments
- 4.10 KPC Group
- 4.10.1 KPC Group Company Information
- 4.10.2 KPC Group Business Overview
- 4.10.3 KPC Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 KPC Group Chloroquine Drug for COVID-19 Product Portfolio
- 4.10.5 KPC Group Recent Developments
- 4.11 CSPC Group
- 4.11.1 CSPC Group Company Information
- 4.11.2 CSPC Group Business Overview
- 4.11.3 CSPC Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CSPC Group Chloroquine Drug for COVID-19 Product Portfolio
- 4.11.5 CSPC Group Recent Developments
5 Global Chloroquine Drug for COVID-19 Market Scenario by Region
- 5.1 Global Chloroquine Drug for COVID-19 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Chloroquine Drug for COVID-19 Sales by Region: 2021-2032
- 5.2.1 Global Chloroquine Drug for COVID-19 Sales by Region: 2021-2026
- 5.2.2 Global Chloroquine Drug for COVID-19 Sales by Region: 2027-2032
- 5.3 Global Chloroquine Drug for COVID-19 Revenue by Region: 2021-2032
- 5.3.1 Global Chloroquine Drug for COVID-19 Revenue by Region: 2021-2026
- 5.3.2 Global Chloroquine Drug for COVID-19 Revenue by Region: 2027-2032
- 5.4 North America Chloroquine Drug for COVID-19 Market Facts & Figures by Country
- 5.4.1 North America Chloroquine Drug for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
- 5.4.3 North America Chloroquine Drug for COVID-19 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Chloroquine Drug for COVID-19 Market Facts & Figures by Country
- 5.5.1 Europe Chloroquine Drug for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
- 5.5.3 Europe Chloroquine Drug for COVID-19 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Chloroquine Drug for COVID-19 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Chloroquine Drug for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Chloroquine Drug for COVID-19 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Chloroquine Drug for COVID-19 Market Facts & Figures by Country
- 5.7.1 South America Chloroquine Drug for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
- 5.7.3 South America Chloroquine Drug for COVID-19 Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Chloroquine Drug for COVID-19 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Chloroquine Drug for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Chloroquine Drug for COVID-19 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Chloroquine Drug for COVID-19 Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Chloroquine Drug for COVID-19 Sales by Type (2021-2032)
- 6.1.1 Global Chloroquine Drug for COVID-19 Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Chloroquine Drug for COVID-19 Sales Market Share by Type (2021-2032)
- 6.2 Global Chloroquine Drug for COVID-19 Revenue by Type (2021-2032)
- 6.2.1 Global Chloroquine Drug for COVID-19 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Chloroquine Drug for COVID-19 Revenue Market Share by Type (2021-2032)
- 6.3 Global Chloroquine Drug for COVID-19 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Chloroquine Drug for COVID-19 Sales by Application (2021-2032)
- 7.1.1 Global Chloroquine Drug for COVID-19 Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Chloroquine Drug for COVID-19 Sales Market Share by Application (2021-2032)
- 7.2 Global Chloroquine Drug for COVID-19 Revenue by Application (2021-2032)
- 7.2.1 Global Chloroquine Drug for COVID-19 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Chloroquine Drug for COVID-19 Revenue Market Share by Application (2021-2032)
- 7.3 Global Chloroquine Drug for COVID-19 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Chloroquine Drug for COVID-19 Value Chain Analysis
- 8.1.1 Chloroquine Drug for COVID-19 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Chloroquine Drug for COVID-19 Production Mode & Process
- 8.2 Chloroquine Drug for COVID-19 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Chloroquine Drug for COVID-19 Distributors
- 8.2.3 Chloroquine Drug for COVID-19 Customers
9 Global Chloroquine Drug for COVID-19 Analyzing Market Dynamics
- 9.1 Chloroquine Drug for COVID-19 Industry Trends
- 9.2 Chloroquine Drug for COVID-19 Industry Drivers
- 9.3 Chloroquine Drug for COVID-19 Industry Opportunities and Challenges
- 9.4 Chloroquine Drug for COVID-19 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst